Lisanti Capital Growth, LLC Sarepta Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$127.12 - $172.34 $1.45 Million - $1.96 Million	-11,400 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $452,724 - $835,835	4,868 Added 74.53%	11,400 $1.83 Million
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $538,106 - $859,872	6,532 New	6,532 $639,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $997,364 - $1.42 Million	-9,350 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $197,559 - $301,982	2,030 Added 27.73%	9,350 $1.02 Million
Q3 2018 Nov 05, 2018	SELL	$115.31 - $161.51 $163,740 - $229,344	-1,420 Reduced 16.25%	7,320 $1.18 Million
Q2 2018 Aug 13, 2018	SELL	$71.74 - $153.69 $1.63 Million - $3.5 Million	-22,780 Reduced 72.27%	8,740 $1.16 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $605,834 - $922,658	11,215 Added 55.23%	31,520 $2.34 Million
Q4 2017 Feb 07, 2018	BUY	$47.64 - $56.75 $432,809 - $515,573	9,085 Added 80.97%	20,305 $1.13 Million
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $400,890 - $529,023	11,220	11,220 $509,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.